Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.65 USD | +0.46% | +3.35% | -31.92% |
Apr. 20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
Apr. 20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.92% | 4.14B | |
+28.29% | 42.68B | |
-2.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.32% | 24.94B | |
-20.71% | 18.96B | |
+28.89% | 12.3B | |
-2.43% | 11.95B | |
-1.14% | 11.55B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target